Akrivia Health
Unlocking real-world data to transform mental health & dementias research, care, and treatment discovery. Join us.
Est 2019
Unlocking real-world data to transform mental health & dementias research, care, and treatment discovery. Join us.
Published Jul 15, 2026
| Starting Price | Not public (custom) | Not public (often enterprise; some academic programs vary) | Not public (custom; large enterprise/project deals) |
| Primary Use Case | UK NHS secondary mental health & dementia RWE; phenotyping from clinical notes; CNS-focused questions | Broad cohort discovery and RWE across large provider networks; feasibility and observational studies | Global-scale RWD portfolios and services; regulatory and commercial evidence programs |
| Key Strength | Specialization in UK secondary mental health & dementia with extensive unstructured note extraction; harmonization across multiple NHS trusts | Large network and cohort exploration tooling | Scale, global coverage, integrated data + services, operational capacity |
| Key Weakness | Limited public reviews; scope primarily secondary care mental health/dementia; pricing transparency low | Data heterogeneity across sites; institutional access constraints; pricing/terms negotiated | Can be expensive/complex; may be less specialized in UK secondary mental health compared to Akrivia |
—